Looks like we have recently operated on another 7 patients successfully in an expansion of the FIH trial. That’s 20 now with 15 to come in the EFS. So by years end we will have a minimum of 35 patients implanted with DurAVR.
That’s a significant milestone that could be a precursor to a partnership.
Ann: FIH Results Presented at EuroPCR & Simultaneous Publication, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.12 |
Change
-0.030(0.49%) |
Mkt cap ! $94.85M | |||
| Open | High | Low | Value | Volume |
| $6.21 | $6.21 | $6.00 | $16.53K | 2.704K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $6.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.08 | 240 | 1 |
View Market Depth
| Last trade - 15.46pm 25/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |